BRAF mutation in progression and therapy of melanoma, papillary thyroid carcinoma and colorectal adenocarcinoma

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

BRAF is mutated at a high frequency in various malignancies, including melanoma, papillary thyroid carcinoma and colorectal adenocarcinoma. BRAF is an element of the RAS/RAF/MEK/ERK (MAPK) pathway, which when constitutively active can lead to increased proliferation rate, enhanced survival, invasion and metastasis. The development of small molecule inhibitors of mutant BRAF kinase has changed the care of patients, especially with melanoma. Despite the success in treating melanoma with inhibitors of mutant BRAF and other elements of RAS/RAF/MEK/ERK (MAPK) pathway, resistance limits the long-term responsiveness to these drugs. The resistance mechanisms to MAPK pathway inhibition are complex, occur at genomic and phenotypic levels, and frequently the same patient can simultaneously develop diverse mechanisms of resistance in different progressive metastases or even in the same lesion. In the current review, we summarize recent research on mutations in BRAF and their importance for the development of tumor. This review will also give an overview on the current knowledge concerning therapies for patients harboring mutation in BRAF and discusses the diverse mechanisms of resistance developed in response to these targeted therapies.

Authors and Affiliations

Izabela Zaleśna, Mariusz L. Hartman, Małgorzata Czyż

Keywords

Related Articles

Effects of lactoferrin on elicitation of the antigen-specific cellular and humoral cutaneous response in mice

Immune contact dermatitis is an inflammation of the skin resulting from exposure to allergens in the environment. The aim of this study was to compare the actions of lactoferrin (LF), a natural immunomodulator, on the el...

Current understanding of allergic march and the role of eczema in its development

An increasing morbidity of atopic diseases (atopic dermatitis, food allergy, asthma and allergic rhinitis) documented in large cohort epidemiological studies is at least partially determined by high hygienic standards of...

Peroxisome proliferator-activated receptors (PPAR). Antiproliferative properties

Peroxisome proliferator-activated receptors (PPAR) are transcription factors that belong to the hormone nuclear receptor superfamily. Their main role is control of fatty acid metabolism and to maintain glucose homeosta...

Rola receptora M1 w regulacji mięśniówki gładkiej dna żołądka

Wstęp: Przedmiotem pracy jest określenie wpływu leków na skurcz mięśniówki gładkiej dna żołądka wyzwalany aktywacją receptorów muskarynowych M1. W przeprowadzonych doświadczeniach badane były interakcje między agonistą r...

Formy morfologiczne Helicobacter pylori i ich przypuszczalna rola w transmisji zakażeń

Ponad połowa światowej populacji ludzi jest zakażona Helicobacter pylori (H. pylori) – Gram-ujemną bakterią, będącą przyczyną rozwoju wrzodów żołądka i dwunastnicy, a także jednym z istotnych czynników w etiopatogenezie...

Download PDF file
  • EP ID EP220698
  • DOI -
  • Views 164
  • Downloads 0

How To Cite

Izabela Zaleśna, Mariusz L. Hartman, Małgorzata Czyż (2016). BRAF mutation in progression and therapy of melanoma, papillary thyroid carcinoma and colorectal adenocarcinoma. Advances in Hygiene and Experimental Medicine, 70(), 471-488. https://www.europub.co.uk/articles/-A-220698